Diese Webseite verwendet Cookies

Diese Seite verwendet Cookies, um Ihnen dieses Angebot leicht zugänglich zu machen, Inhalte zu personalisieren, Ihre Zugriffe auf die Webseite zu analysieren und Ihnen ggf. personalisierte Angebote unterbreiten zu können. Hierzu kann es notwendig sein, dass die Informationen über Ihre Verwendung der Webseite an Partner weitergegeben werden. Diese führen die gesammelten Informationen möglicherweise mit weiteren Daten zusammen, die Sie an anderer Stelle bereitgestellt haben. Eine Weitergabe erfolgt dabei aber nur mit Ihrer Einwilligung und unter Beachtung der datenschutzrechtlichen Vorgaben. Weiterführende Informationen über die hier verwendeten Cookies erfahren Sie in den folgenden Erklärungen zu den jeweiligen Cookies.

Notwendige Cookies helfen dabei, Ihnen die Funktionen der Webseite zugängig zu machen, indem sie Grundfunktionen die zuletzt angesehen Wertpapiere und Ihre Entscheidung für oder gegen die Nutzung der jeweiligen Cookies speichert. Die Webseite wird ohne diese Cookies nicht so funktionieren, wie es geplant ist.

Name Anbieter Zweck Ablauf Typ Verantwortlicher
CookieConsent2133 Moneyspecial Um diese Cookiebar auszublenden. 1 Jahr http Infront Financial Technology GmbH
Die Cookie-Erklärung wurde das letzte Mal am 27.07.2020 von Infront Financial Technology GmbH aktualisiert.


Global Leader in Women's Health to Present Research and Educational Opportunities Focused on Improving Workflow and Efficiency

MARLBOROUGH, Mass. --(BUSINESS WIRE)-- 27.02.2024 --

Hologic, Inc. (Nasdaq: HOLX) continues to deliver on its commitment to advancing women's health by unveiling new research in artificial intelligence (AI) and offering innovative educational opportunities at the annual European Congress of Radiology (ECR) in Vienna, Austria from February 28 to March 2.

The pioneer behind 3D mammography, Hologic will present new data that showcase how next-generation deep-learning solutions can assist with breast cancer detection and improve workflow for radiologists. Presented by esteemed breast imaging specialist and study author Dr. Sarah M. Friedewald, Associate Professor of Radiology and Chief of Breast Imaging at Northwestern Memorial Hospital, the research shows that Hologic's Genius AI® Detection solution has an exceptional ability to correctly match pairs of Regions of Interest (ROIs) in different views.1

"These data reveal how AI can help us correlate ROIs in a way that we have never seen before, which underscores that deep-learning technology can supplement our workflow as radiologists and help us provide better patient care," said Dr. Friedewald. "Beyond its impact on our daily practices, these data emphasize the transformative potential AI has to drive improvements across the breast health spectrum. I'm looking forward to sharing this information with my colleagues from around the globe at ECR."

In addition, Dr. Friedewald will also present research highlighting how the Genius AI Detection algorithm can help radiologists identify potential cancers on mammograms previously interpreted as normal.2 In a third study, research will be presented that demonstrates Hologic's deep learning-based AI algorithm can help significantly enhance performance, surpassing traditional machine learning Computer-Aided Detection (CAD) algorithms in specificity and overall effectiveness.3

"Research and education are central tenets of Hologic's innovation, to support radiologists in achieving better patient outcomes," said Tanja Brycker, Vice President, Strategic Development, Breast & Skeletal Health and Gynecological Surgical Solutions at Hologic. "We're excited to present groundbreaking research at ECR and to continue our collaboration with Bayer on contrast-enhanced mammography. By offering our customers the opportunity to engage with world-renowned experts and explore our latest technology, we are ensuring they feel confident in their patient care procedures and decisions."

Hologic and Bayer will co-sponsor a contrast-enhanced mammography (CEM) symposium, facilitated by globally recognized breast imaging radiologists Dr. Jacopo Nori, Chief of Breast Imaging at Careggi University Hospital in Florence, Italy, and Dr. Marc Lobbes, Chairperson of the Board, Department of Medical Imaging at Zuyderland Medical Center in Sittard-Geleen, the Netherlands.

The symposium, which will take place on Thursday, February 29 at 11 a.m. CET, is designed to provide radiologists with an understanding of how CEM can be effectively implemented into their daily practice.

Hologic's Genius AI® Detection technology is a cutting-edge solution now commercially available in the U.S., with plans for rollout in Europe, Canada and Asia by the end of 2024.

About Hologic, Inc.

Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment. Its advancements include invention of the world's first commercial 3D mammography system to find breast cancer earlier; leadership in testing for cervical cancer, sexually transmitted infections and respiratory illnesses; and minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding.

The company also champions women through the Hologic Global Women's Health Index, which provides a science-backed data framework for improving women's well-being.

Forward-Looking Statements

This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.

This information is not intended as a product solicitation or promotion where such activities are prohibited. For specific information on what products are available for sale in a particular country, please contact a local Hologic sales representative or write to womenshealth@hologic.com.

Hologic, The Science of Sure and Genius AI are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

Views and opinions expressed herein by third parties are theirs alone and do not necessarily reflect those of Hologic. Dr. Sarah M. Friedewald is a paid Hologic consultant.

Source: Hologic, Inc.



Correlating breast lesions in tomosynthesis CC and MLO views using artificial intelligence (AI). Authors: Sarah Friedewald (Northwestern), Chirag Phargi (Solis). Accepted as podium presentation.


Evaluating performance of an artificial intelligence (AI) detection system on prior screening tomosynthesis studies of breast cancer patients. Authors: Sarah Friedewald (Northwestern), Chirag Phargi (Solis). Accepted as podium presentation.


Performance of a traditional machine learning computer-aided detection (CADe) algorithm versus a deep learning artificial intelligence (AI) algorithm on digital breast tomosynthesis (DBT) studies. Authors: Manisha Bahl (MGH), Constance Lehman (MGH). Accepted as electronic poster.


Media Contact
Bridget Perry
Director, Corporate Communications
+1 508.263.8654

Investor Contact
Ryan M. Simon
Vice President, Investor Relations
+1 858.410.8514

Business Wire

Zeit Meldung
12.04. BUSINESS WIRE: Jahresbericht 2023 der BM3EAC Corp.
12.04. BUSINESS WIRE: Indri wird zur am schnellsten wachs
12.04. BUSINESS WIRE: Spiber Inc. sammelt über 10 Milliar
11.04. BUSINESS WIRE: Contentful ernennt Karthik Rau zum
11.04. BUSINESS WIRE: Zywave kooperiert mit HTEC bei der
11.04. BUSINESS WIRE: ExaGrid zum Finalisten der Storage
11.04. BUSINESS WIRE: Talkdesk stellt den Innovator für k
11.04. BUSINESS WIRE: Nike Kicks Off Multi-Year Innovatio
11.04. BUSINESS WIRE: Crown Bioscience erhält die CAP 151
11.04. BUSINESS WIRE: Vantage Data Centers erweitert sein
11.04. BUSINESS WIRE: Rhône Energies hat exklusive Verhan
11.04. BUSINESS WIRE: Telix Pharmaceuticals Limited schli
11.04. BUSINESS WIRE: Rimini Street ernennt Martyn Hoogak
11.04. BUSINESS WIRE: o9 schließt erfolgreiche 6-Monate-I
11.04. BUSINESS WIRE: Estée Lauder engagiert koreanische
11.04. BUSINESS WIRE: Muratas bahnbrechendes keramisches
11.04. BUSINESS WIRE: Giesecke+Devrient Sets New Highs an
11.04. BUSINESS WIRE: NetApp schließt Partnerschaft mit G
11.04. BUSINESS WIRE: APRIL Group Launches Its Spring 202
11.04. BUSINESS WIRE: oceansix beauftragt US-amerikanisch
11.04. BUSINESS WIRE: Gurobi startet kostenlosen Massive
11.04. BUSINESS WIRE: FluxSwiss und SwissAI arbeiten bei
11.04. BUSINESS WIRE: Go Reply erhält den Google Cloud Pa
11.04. BUSINESS WIRE: Weltweite Initiative "Quit like Swe
11.04. BUSINESS WIRE: Blue Yonder kündigt Vereinbarung zu

Mehr Marktdaten und Kurse finden Sie auf www.finanztreff.de

Angebote der
Nutzungshinweise | Datenschutz | Impressum | Datenquellen: boerse-stuttgart.de,